Before The Bell
FONT-SIZE Plus   Neg

Regeneron Pharmaceuticals (REGN) Rose To A New High For The Year

Regeneron Pharmaceuticals (REGN: Quote) traded to the upside throughout the first half of Wednesday's session and took out the highs of the day going into the close. The stock finished with a gain of 10.05 at $201.13.

Regeneron Pharmaceuticals has been gaining ground for nearly 2 weeks and set a new high for the year.

Click here to receive FREE breaking news email alerts for Regeneron Pharmaceuticals and others in your portfolio

by RTT Staff Writer

For comments and feedback:

Business News

comments powered by Disqus